Codexis
CDXS

Codexis (CDXS) analyst forecast and price target

Analyst forecast

Buy

Consensus of 8 analyst ratings

Buy
6
Hold
2
Sell
0

Recent analyst ratings

FirmActionRatingPrice targetDate
Piper SandlerMaintainedOverweight$8.00 from $9.00Aug 17, 2026
Cantor FitzgeraldMaintainedOverweight$11.00Nov 22, 2024
Cantor FitzgeraldMaintainedOverweight$11.00Nov 15, 2024
BenchmarkMaintainedHold—Nov 4, 2024
Cantor FitzgeraldMaintainedOverweight$11.00Sep 20, 2024
Cantor FitzgeraldMaintainedOverweight$11.00Aug 29, 2024
BenchmarkDowngradedBuy → Hold—Aug 19, 2024
Cantor FitzgeraldMaintainedOverweight$11.00Aug 9, 2024
Cantor FitzgeraldInitiated CoverageOverweight$11.00May 30, 2024
BenchmarkMaintainedBuy$9.00May 3, 2024
BenchmarkUpgradedHold → Buy$9.00Feb 29, 2024
BenchmarkDowngradedBuy → Hold—Nov 7, 2023
Piper SandlerMaintainedOverweight$10.00 from $14.00Nov 6, 2023
BenchmarkMaintainedBuy$9.00Sep 1, 2023
StifelMaintainedBuy$5.00 from $9.00Aug 14, 2023
Stephens & Co.MaintainedOverweight$6.00Jul 21, 2023
BenchmarkMaintainedBuy$9.00 from $15.00May 9, 2023
HC Wainwright & Co.DowngradedBuy → Neutral—May 9, 2023

Frequently asked questions

  • Is CDXS a buy, sell, or hold?

    Analysts covering Codexis currently average a Buy rating: 6 buy, 2 hold and 0 sell, from 8 analysts. Ratings reflect analyst opinion, not investment advice.

  • What is the latest analyst rating on CDXS?

    On Aug 17, 2026, Piper Sandler maintained Codexis at Overweight with a price target of $8.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.